|
TSC22D2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.38029999991107E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.96369999996937E-06 |
| Normal-vs-Stage2 |
2.26689999999197E-05 |
| Normal-vs-Stage3 |
4.835600E-01 |
| Normal-vs-Stage4 |
2.984000E-04 |
| Stage1-vs-Stage2 |
6.180200E-01 |
| Stage1-vs-Stage3 |
1.648180E-01 |
| Stage1-vs-Stage4 |
5.631600E-01 |
| Stage2-vs-Stage3 |
2.052800E-01 |
| Stage2-vs-Stage4 |
8.489400E-01 |
| Stage3-vs-Stage4 |
2.402400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64386000000016E-05 |
| Normal-vs-AfricanAmerican |
1.83145000000051E-05 |
| Normal-vs-Asian |
9.846200E-02 |
| Caucasian-vs-AfricanAmerican |
5.448800E-01 |
| Caucasian-vs-Asian |
7.179200E-01 |
| AfricanAmerican-vs-Asian |
3.287000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.327399999975E-06 |
| Normal-vs-Female |
2.322500E-02 |
| Male-vs-Female |
3.773500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.86652999999426E-05 |
| Normal-vs-Extreme_Weight |
1.94360000005389E-06 |
| Normal-vs-Obese |
1.128360E-02 |
| Normal-vs-Extreme_Obese |
1.649720E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.107600E-01 |
| Normal_Weight-vs-Obese |
2.889000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.959400E-01 |
| Extreme_Weight-vs-Obese |
1.546810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.274020E-01 |
| Obese-vs-Extreme_Obese |
7.486800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.394000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.83810999999645E-05 |
| Normal-vs-Age(61-80Yrs) |
2.91029999999193E-06 |
| Normal-vs-Age(81-100Yrs) |
1.5492999999589E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.244220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.073820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.378200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.998800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.313200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.380200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.34789999997709E-06 |
| Normal-VS-Type2 PRCC |
1.6209999999961E-05 |
| Normal-VS-KIRP CIMP |
4.051200E-01 |
| Normal-VS-Unclassified PRCC |
1.049480E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.143000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.249010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.415370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.334370E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.495400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.510420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07399999996305E-06 |
| Normal-vs-N1 |
9.073800E-01 |
| Normal-vs-N2 |
6.114300E-02 |
| N0-vs-N1 |
1.037170E-01 |
| N0-vs-N2 |
9.454800E-01 |
| N1-vs-N2 |
1.343410E-01 |
|
|
